DK0398230T3 - Antivirale, meget vandopløselige, stabile, krystallinske salte af 2',3'-dideoxyinosin,monohydrat,2',3'-dideoxy-2',3'-didehy - Google Patents

Antivirale, meget vandopløselige, stabile, krystallinske salte af 2',3'-dideoxyinosin,monohydrat,2',3'-dideoxy-2',3'-didehy

Info

Publication number: DK0398230T3
Authority: DK; Denmark
Prior art keywords: dideoxy; dideoxyinosine; stable; antiviral; highly water
Prior art date: 1989-05-15

Application number

DK90109065T

Other languages

English (en)

Inventor

Murray Arthur Kaplan

Robert Kevin Perrone

Joseph Ballard Bogardus

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-15

Filing date

1990-05-14

Publication date

1998-09-21

1990-05-14 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1998-09-21 Application granted granted Critical

1998-09-21 Publication of DK0398230T3 publication Critical patent/DK0398230T3/da

Links

150000003839 salts Chemical class 0.000 title abstract 3
BXZVVICBKDXVGW-NKWVEPMBSA-N Didanosine Chemical class O1[C@H](CO)CC[C@@H]1N1C(NC=NC2=O)=C2N=C1 BXZVVICBKDXVGW-NKWVEPMBSA-N 0.000 title 1
230000000840 anti-viral effect Effects 0.000 title 1
150000004682 monohydrates Chemical class 0.000 title 1
239000003443 antiviral agent Substances 0.000 abstract 1
150000001767 cationic compounds Chemical group 0.000 abstract 1
229960002656 didanosine Drugs 0.000 abstract 1
229910001411 inorganic cation Chemical group 0.000 abstract 1
150000002892 organic cations Chemical group 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Oncology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

DK90109065T 1989-05-15 1990-05-14 Antivirale, meget vandopløselige, stabile, krystallinske salte af 2',3'-dideoxyinosin,monohydrat,2',3'-dideoxy-2',3'-didehy DK0398230T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35206589A	1989-05-15	1989-05-15
US51426190A	1990-05-01	1990-05-01

Publications (1)

Publication Number	Publication Date
DK0398230T3 true DK0398230T3 (da)	1998-09-21

Family

ID=26997373

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90109065T DK0398230T3 (da)	1989-05-15	1990-05-14	Antivirale, meget vandopløselige, stabile, krystallinske salte af 2',3'-dideoxyinosin,monohydrat,2',3'-dideoxy-2',3'-didehy

Country Status (16)

Country	Link
EP (1)	EP0398230B1 (da)
KR (1)	KR970001160B1 (da)
CN (2)	CN1027896C (da)
AT (1)	ATE162528T1 (da)
AU (1)	AU617614B2 (da)
BG (1)	BG60517B1 (da)
DE (1)	DE69031962T2 (da)
DK (1)	DK0398230T3 (da)
EG (1)	EG19154A (da)
ES (1)	ES2113851T3 (da)
FI (1)	FI95269C (da)
GR (1)	GR3025984T3 (da)
HU (1)	HU206628B (da)
IE (1)	IE81107B1 (da)
NO (2)	NO174102C (da)
PT (1)	PT94040B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO920714L (no) *	1991-03-01	1992-09-02	Bristol Myers Squibb Co	Tetrahydrofuran-mellomprodukt
US5221611A (en) *	1991-06-19	1993-06-22	Sigma Chemical Company	Ddi immunoassays, derivatives, conjugates and antibodies
US5589587A (en) *	1992-05-12	1996-12-31	Merrell Pharmaceuticals Inc.	Process for the preparation of ribonucleotide reductase inhibitors
JPH09511227A (ja) *	1994-01-07	1997-11-11	メレルファーマスーティカルズインコーポレイテッド	（ｅ）−２’−デオキシ−２’−（フルオロメチレン）シチジンの一水和物
WO2006007448A2 (en) *	2004-06-17	2006-01-19	Transform Pharmaceuticals, Inc.	Pharmaceutical co-crystal compositions and related methods of use
US8445669B2 (en)	2008-04-10	2013-05-21	Hamari Chemicals, Ltd.	Production process of ethynylthymidine compounds from 5-methyluridine as a starting material

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1987001284A1 (en) *	1985-08-26	1987-03-12	United States Of America, Represented By The Unite	Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
KR960001372B1 (ko) *	1986-09-24	1996-01-26	예일 유니버시티	레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
US4978655A (en) *	1986-12-17	1990-12-18	Yale University	Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
CA1340645C (en) *	1987-04-17	1999-07-13	Victor E. Marquez	Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
IL89258A0 (en) *	1988-02-16	1989-09-10	Lilly Co Eli	2',3'-dideoxy-2',2'-difluoro-nucleosides
GB8823319D0 (en) *	1988-10-05	1988-11-09	Nycomed As	Chemical compounds

1990
- 1990-05-11 FI FI902360A patent/FI95269C/fi active IP Right Grant
- 1990-05-14 DE DE69031962T patent/DE69031962T2/de not_active Expired - Fee Related
- 1990-05-14 AU AU55011/90A patent/AU617614B2/en not_active Ceased
- 1990-05-14 IE IE173490A patent/IE81107B1/en not_active IP Right Cessation
- 1990-05-14 BG BG92000A patent/BG60517B1/bg unknown
- 1990-05-14 EP EP90109065A patent/EP0398230B1/en not_active Expired - Lifetime
- 1990-05-14 KR KR1019900006857A patent/KR970001160B1/ko not_active Expired - Fee Related
- 1990-05-14 CN CN90103580A patent/CN1027896C/zh not_active Expired - Fee Related
- 1990-05-14 AT AT90109065T patent/ATE162528T1/de not_active IP Right Cessation
- 1990-05-14 EG EG28490A patent/EG19154A/xx active
- 1990-05-14 ES ES90109065T patent/ES2113851T3/es not_active Expired - Lifetime
- 1990-05-14 DK DK90109065T patent/DK0398230T3/da active
- 1990-05-15 NO NO902148A patent/NO174102C/no unknown
- 1990-05-15 HU HU903038A patent/HU206628B/hu not_active IP Right Cessation
- 1990-05-15 PT PT94040A patent/PT94040B/pt not_active IP Right Cessation
1993
- 1993-09-22 NO NO933367A patent/NO176609C/no unknown
1994
- 1994-08-23 CN CN94116469A patent/CN1057443C/zh not_active Expired - Fee Related
1998
- 1998-01-22 GR GR970403458T patent/GR3025984T3/el unknown

Also Published As

Publication number	Publication date
EP0398230B1 (en)	1998-01-21
EP0398230A3 (en)	1991-06-26
HUT53528A (en)	1990-11-28
CN1027896C (zh)	1995-03-15
NO176609C (no)	1995-05-03
NO174102B (no)	1993-12-06
FI902360A0 (fi)	1990-05-11
EG19154A (en)	1994-09-29
PT94040B (pt)	1996-12-31
BG92000A (bg)	1993-12-24
IE81107B1 (en)	2000-03-08
IE901734L (en)	1990-11-15
FI95269C (fi)	1996-01-10
AU617614B2 (en)	1991-11-28
NO902148D0 (no)	1990-05-15
KR900017591A (ko)	1990-12-19
NO933367L (no)	1990-11-16
NO933367D0 (no)	1993-09-22
FI95269B (fi)	1995-09-29
HU903038D0 (en)	1990-09-28
DE69031962D1 (de)	1998-02-26
NO176609B (no)	1995-01-23
CN1057443C (zh)	2000-10-18
ES2113851T3 (es)	1998-05-16
EP0398230A2 (en)	1990-11-22
GR3025984T3 (en)	1998-04-30
HU206628B (en)	1992-12-28
AU5501190A (en)	1990-11-15
ATE162528T1 (de)	1998-02-15
BG60517B1 (bg)	1995-07-28
KR970001160B1 (ko)	1997-01-29
DE69031962T2 (de)	1998-09-17
PT94040A (pt)	1991-01-08
NO902148L (no)	1990-11-16
CN1047676A (zh)	1990-12-12
CN1109755A (zh)	1995-10-11
NO174102C (no)	1994-03-16

Publication	Publication Date	Title
ATE157095T1 (de)	1997-09-15	Hydroxymethyl(methylencyclopentyl)purinen und pyrimidinen
DK0388948T3 (da)	1994-01-24	Acryloylsubstituerede pyrrolderivater
DK506587A (da)	1988-03-27	Imidderivater
ES2046229T3 (es)	1994-02-01	Composicion antiulcerosa.
DK0398230T3 (da)	1998-09-21	Antivirale, meget vandopløselige, stabile, krystallinske salte af 2',3'-dideoxyinosin,monohydrat,2',3'-dideoxy-2',3'-didehy
MY116824A (en)	2004-04-30	Antivaral,highly water soluble,stable,crystalline salts of 2'',3''-dideoxyinosine monohydrate,2'',3''-dideoxy-2'' ,3''-didehydrothymidine monohydrate and 2'',3''-dideoxy-2''-fluoroinosine hemihydrate
ES2093051T3 (es)	1996-12-16	Purinil- y pirimidil-tetrahidrofuranos.
ATE112284T1 (de)	1994-10-15	Exo-3'-4'-o-benzyliden-3''-demethylchartreusin und seine salze.